article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105
article thumbnail

Press Release: Launch of the Psychedelic Access and Research European Alliance – PAREA

Cannabis Law Report

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. Psychedelic compounds – such as psilocybin and MDMA – are one such extremely promising area.

Access 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mind Medicine Australia – Opinion: If the Medicine Works Shouldn’t We All Have Access to it? A Recent Poll of Australians Says Yes We Should – Scott Leckie and Tania de Jong (February 2022)

Cannabis Law Report

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Adverse events were mostly mild and resolved spontaneously. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs. The 1mg dose showed a significant pain decrease compared to the placebo.

article thumbnail

Mind Medicine Australia Webinar : Helping to change policy – Influencing the TGA with Prof. David Nutt (UK)

Cannabis Law Report

Event description Don’t miss out – Get your tickets early! Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

Policy 52
article thumbnail

New Issue of the ASA Activist Newsletter is out!

Americans for Safe Access

You'll also find a link to the new issue of Cannabis Patient Care Magazine, a free benefit to ASA members, that this month features important information about coping with breast cancer treatment.

Events 162
article thumbnail

Modern Compassionate Care offers more than medical cards

Illinois News Joint

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. One of our main goals is to increase the accessibility and affordability of medical cannabis as a treatment.”